| Serial Number | 97131817 |
| Word Mark | LIST BIOTHERAPEUTICS |
| Filing Date | Thursday, November 18, 2021 |
| Status | 807 - SU - NON-FINAL ACTION - MAILED |
| Status Date | Friday, May 31, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 7, 2023 |
| Goods and Services | Biological products and preparations for use in scientific research, namely, proteins, polypeptides, peptides, toxins, neurotoxin, antisera and inmmunotoxins, lipopolysaccharides, microorganism, microbiome, probiotics, prebiotics, bacteria, bacterial extracts, adjuvants; cell culture media being bacterial cultures for laboratory use; chemical analysis testing kits containing peptide substrates used in testing certain toxins and neurotoxins for laboratory use; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use |
| NOT AVAILABLE | "BIOTHERAPEUTICS" |
| Goods and Services | Chemical laboratories; chemical research; chemical, biochemical, biological and bacteriological research and analysis; biological research and analysis; research and development of pharmaceutical preparations and medicines as a contract development and manufacturing organization; pharmaceutical drug development services in the fields of substance and drug product manufacturing as a contract development and manufacturing organization; consulting services in the fields of biotechnology, pharmaceutical research and development, biotherapeutics, and cellular science; biopharmaceutical product development services; testing of pharmaceuticals, specifically, analytical development services for others in the fields of biotherapeutics and biological products; research and development services in the medical and pharmaceutical fields; services for the development and testing of pharmaceutical products; consulting services in the sectors of biotherapeutics, diagnostics and laboratory testing techniques; pharmaceutical product development of biotherapeutic formulations comprised of live bacterial cultures, reagents and pharmaceutical products |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 23, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | Wednesday, June 8, 2022 |
| First Use In Commerce Date | Wednesday, June 8, 2022 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 23, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, June 8, 2022 |
| First Use In Commerce Date | Wednesday, June 8, 2022 |
| Party Name | LIST BIOTHERAPEUTICS, INC. |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 03 - Corporation |
| Address | INDIANAPOLIS, IN 46256 |
| Party Name | GENOME AND COMPANY |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Gyeonggi-do 13486 KR |
| Party Name | GENOME AND COMPANY |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Gyeonggi-do 13486 KR |
| Event Date | Event Description |
| Thursday, June 16, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, November 22, 2021 | NEW APPLICATION ENTERED |
| Tuesday, November 23, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, June 9, 2022 | ASSIGNED TO EXAMINER |
| Thursday, June 16, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, June 16, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, December 15, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, December 15, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 15, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 3, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 18, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 7, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 7, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, February 22, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, April 4, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, October 4, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, October 4, 2023 | SOU EXTENSION 1 FILED |
| Wednesday, October 4, 2023 | SOU EXTENSION 1 GRANTED |
| Friday, October 6, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, April 4, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, April 4, 2024 | USE AMENDMENT FILED |
| Thursday, April 25, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, April 25, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, May 8, 2024 | ASSIGNED TO EXAMINER |
| Friday, May 31, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, May 31, 2024 | SU - NON-FINAL ACTION - WRITTEN |
| Friday, May 31, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, August 27, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |